William Blair & Company
ONC

William Blair & Company’s BeOne Medicines Ltd ONC Stock Holding History

William Blair & Company’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,004
Closed -$216K – 1879
2023
Q1 		$216K Buy
1,004
+4
+0.4% +$959 ﹤0.01% 1374
2022
Q4 		$220K Buy
+1,000
New +$183K ﹤0.01% 1335
2022
Q2 		– Sell
-1,084
Closed -$204K – 1954
2022
Q1 		$204K Buy
1,084
+1
+0.1% +$213 ﹤0.01% 1504
2021
Q4 		$293K Buy
1,083
+333
+44% +$112K ﹤0.01% 1431
2021
Q3 		$272K Sell
750
-50
-6% -$16.3K ﹤0.01% 1368
2021
Q2 		$275K Hold
800
– – ﹤0.01% 1374
2021
Q1 		$278K Sell
800
-62
-7% -$20.5K ﹤0.01% 1358
2020
Q4 		$223K Sell
862
-43
-5% -$11.8K ﹤0.01% 1386
2020
Q3 		$259K Buy
+905
New +$213K ﹤0.01% 1195
2019
Q1 		– Sell
-1,490
Closed -$209K – 1743
2018
Q4 		$209K Hold
1,490
– – ﹤0.01% 1219
2018
Q3 		$257K Hold
1,490
– – ﹤0.01% 1205
2018
Q2 		$229K Buy
1,490
+40
+3% +$7.13K ﹤0.01% 1225
2018
Q1 		$244K Sell
1,450
-815
-36% -$110K ﹤0.01% 1148
2017
Q4 		$221K Sell
2,265
-100
-4% -$9.15K ﹤0.01% 1236
2017
Q3 		$245K Buy
+2,365
New +$176K ﹤0.01% 1192

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

William Blair & Company's ONC Position: Q2 2023 in Review

William Blair & Company sold out of BeOne Medicines Ltd (ONC) in Q2 2023, closing a stake of 1,004 shares — an estimated $216K sold.

William Blair & Company first reported a position in ONC in Q3 2017 and held it in 15 quarters. The position peaked at $293K in Q4 2021. 208 funds tracked by Wall St. Rank hold ONC as of Q2 2023.

  • William Blair & Company reported no remaining BeOne Medicines Ltd position as of Q2 2023 after selling out during the quarter.
  • William Blair & Company sold 1,004 BeOne Medicines Ltd shares in Q2 2023, an estimated $216K.
  • William Blair & Company first reported a position in BeOne Medicines Ltd in Q3 2017 and held it in 15 quarters.
  • William Blair & Company's BeOne Medicines Ltd position peaked at $293K in Q4 2021.
  • 208 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2023.

Based on William Blair & Company's 13F filing for Q2 2023, filed 11 Aug 2023.